Universal Biosensors, Inc. announced that the Board has appointed Mr. Salesh Balak, UBI's Chief Financial Officer and Company Secretary, as its interim Principal Executive Officer. This appointment will be effective from July 15, 2019 being the current CEO's last date with the company. The appointment is on an interim basis until the company has more clarity on its strategic direction which is highly dependent on the outcome of its commercial discussions and negotiations with Siemens.

During the interim period, the company will be run by an Executive Committee chaired by Mr. Salesh Balak. The Executive Committee includes Mr. Balak, Ms. Judy Andrews, Director, Operations and Manufacturing Engineering and Ms. Sarah Phillips, Director, Program Management & Clinical Affairs.